Older Adults with Mild Cognitive Impairment Can Reliably Express Their Preferences for Health Care Using Discrete Choice Experiments

Published Jul 3, 2014
Adelaide, South Australia – Researchers from Flinders University found that mild cognitive impairment did not affect the ability of older adults to reliably respond to questions about their preferred rehabilitation services following hip fracture. Older adults (aged 65 years and over) represent an increasing proportion of the population with rising expectations for quality health and aged care services targeted to meet their needs and preferences. A recent study, “Cognitive Overload? An Exploration of the Potential Impact of Cognitive Functioning in Discrete Choice Experiments with Older People in Health Care,” published in Value in Health, was among the first to use discrete choice experiments (DCE), a popular method for quantifying preferences, to focus on older people, especially those with cognitive impairment. Through the use of a questionnaire completed by 74 older adults in the acute phase following a hip fracture to determine whether cognition influenced their ability to reliably complete a DCE, the researchers found that in comparison with those with good cognitive functioning, mild cognitive impairment did not influence the ability of older adults to respond reliably. Study co-author Professor Julie Ratcliffe, PhD, from Flinders University says, “This study demonstrates the ability of older adults, including those with mild cognitive impairment, to make reliable choices in relation to the characteristics of care of importance to them, and demonstrates the potential for the wider utilization of DCE methods to elicit treatment and service preferences across health and aged care sectors.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Sep 3, 2025

Value in Health, the official journal of ISPOR announced the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.

ISPOR Champions Research Transparency With Launch of Open Science Badges

Aug 4, 2025

ISPOR introduced an initiative to recognize transparency in research for papers published in Value in Health, its preeminent HEOR journal.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×